UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.49 | -0.49 |
| Q1 2022 | 2022-05-10 | -0.53 | -0.53 |
| Q4 2021 | 2022-03-01 | -0.37 | -0.37 |
| Q3 2021 | 2021-11-09 | -0.36 | -0.36 |
| Q2 2021 | 2021-08-09 | -0.46 | -0.46 |
| Q1 2021 | 2021-05-10 | -0.57 | -0.57 |
| Q4 2020 | 2021-03-01 | -0.60 | -0.60 |
| Q3 2020 | 2020-11-09 | -0.66 | 0.00 |
| Q2 2020 | 2020-08-10 | -0.61 | -0.61 |
| 2016-06-29 | Reiterated Rating | FBR & Co. | Outperform | |
| 2016-06-29 | Reiterated Rating | FBR & Co | Outperform | $38.00 |
| 2016-06-14 | Reiterated Rating | WBB Securities | Buy | $75.00 |
| 2016-06-04 | Initiated Coverage | Maxim Group | Buy | |
| 2016-06-02 | Initiated Coverage | Cantor Fitzgerald | Buy | $21.00 |
| 2016-05-19 | Reiterated Rating | Maxim Group | Buy | $30.00 |
| 2016-05-10 | Reiterated Rating | Wedbush | Outperform | $62.00 |
| 2016-05-10 | Reiterated Rating | Maxim Group | Buy | |
| 2016-04-20 | Reiterated Rating | Maxim Group | Buy | |
| 2016-03-09 | Reiterated Rating | Maxim Group | Buy | $30.00 |
| 2016-03-08 | Reiterated Rating | Wedbush | Outperform | $62.00 |
| 2016-03-02 | Lower Price Target | Needham & Company LLC | Buy | $30.00 to $28.00 |
| 2016-02-29 | Lower Price Target | Wedbush | Outperform | $65.00 to $62.00 |
| 2016-02-24 | Reiterated Rating | Maxim Group | Buy | $30.00 |
| 2016-01-04 | Reiterated Rating | Wedbush | Outperform | $65.00 |
| 2015-11-11 | Lower Price Target | Wedbush | Outperform | $70.00 to $65.00 |
| 2015-11-10 | Reiterated Rating | Needham & Company LLC | Buy | $32.00 to $30.00 |
| 2015-10-30 | Reiterated Rating | FBR & Co. | Outperform | |
| 2015-08-31 | Reiterated Rating | Needham & Company LLC | Buy | $32.00 |
| 2015-08-19 | Reiterated Rating | Maxim Group | Buy | $30.00 |
| 2015-08-19 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-08-18 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-08-18 | Boost Price Target | Wedbush | Outperform | $61.00 to $70.00 |
| 2015-08-18 | Boost Price Target | WBB Securities | Strong-Buy | $60.00 to $75.00 |
| 2015-08-11 | Reiterated Rating | MLV & Co. | Buy | $38.00 |
| 2015-08-11 | Reiterated Rating | Wedbush | Buy | $61.00 |
| 2015-08-10 | Initiated Coverage | Roth Capital | Buy | $38.00 |
| 2015-07-23 | Reiterated Rating | Wedbush | Buy | $61.00 |
| 2015-07-12 | Reiterated Rating | Wedbush | Outperform | $61.00 |
| 2015-07-02 | Reiterated Rating | Wedbush | Buy | $61.00 |
| 2015-06-18 | Reiterated Rating | MLV & Co. | Buy | $38.00 |
| 2015-04-14 | Set Price Target | MLV & Co. | Buy | $38.00 |
| 2015-04-14 | Set Price Target | Wedbush | Buy | $61.00 |
| 2015-04-06 | Set Price Target | Wedbush | Buy | $61.00 |
| 2015-03-17 | Set Price Target | Needham & Company LLC | Buy | $22.00 to $32.00 |
| 2015-03-13 | Set Price Target | MLV & Co. | Buy | $38.00 |
| 2015-02-20 | Boost Price Target | Maxim Group | Buy | $28.00 to $30.00 |
| 2015-02-19 | Set Price Target | Wedbush | Buy | $52.00 |
| 2015-02-18 | Boost Price Target | MLV & Co. | Buy | $19.00 to $38.00 |
| 2014-11-13 | Boost Price Target | Maxim Group | Buy | $20.00 to $28.00 |
| 2014-10-31 | Set Price Target | Needham & Company LLC | $17.00 to $22.00 | |
| 2014-04-07 | Reiterated Rating | Needham & Company LLC | Buy | $15.00 to $17.00 |
| 2014-04-07 | Boost Price Target | WBB Securities | Strong-Buy | $20.00 to $30.00 |
| 2014-03-25 | Reiterated | Needham | Buy | $15 to $17 |
| 2014-03-25 | Boost Price Target | Needham & Company LLC | Buy | $15.00 to $17.00 |
| 2014-03-19 | Boost Price Target | Wedbush | $32.00 to $37.00 | |
| 2013-12-16 | Reiterated Rating | Wedbush | Top Pick | $32.00 |
| 2013-11-07 | Boost Price Target | Needham & Company LLC | Buy | $12.00 to $15.00 |
| 2013-10-02 | Boost Price Target | Wedbush | $28.00 to $32.00 | |
| 2013-09-16 | Reiterated Rating | Wedbush | Outperform | $28.00 |
| 2013-04-15 | Initiated | MLV & Co | Buy | $14 |
| 2012-12-28 | Reiterated | Burrill Institutional Research | Mkt Outperform | $19 to $16 |
| 2012-12-04 | Upgrade | Needham | Hold to Buy | $10 |
| 2012-10-15 | Initiated | Burrill Institutional Research | Mkt Outperform | $17 |
| 2012-07-30 | Reiterated | Maxim Group | Buy | $23 to $25 |
| 2012-05-08 | Initiated | Maxim Group | Buy | $23 |
| 2012-03-22 | Reiterated | WBB Securities | Strong Buy | $10.50 to $20 |
| 2012-03-14 | Upgrade | Canaccord Genuity | Hold to Buy | $5 to $13 |
| 2012-03-13 | Reiterated | Rodman & Renshaw | Mkt Outperform | $13 to $16 |
| 2011-12-05 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $13 |
| 2011-04-01 | Downgrade | Rodman & Renshaw | Mkt Outperform to Mkt Perform | |
| 2011-04-01 | Downgrade | Deutsche Bank | Buy to Hold | $13 to $6 |
| 2010-10-26 | Upgrade | WBB Securities | Buy to Strong Buy | $9 to $10.50 |
| 2010-09-10 | Initiated | Rodman & Renshaw | Mkt Outperform | $20 |
| 2009-12-01 | Initiated | Needham | Buy | $10 |
| 2009-11-20 | Initiated | Wedbush Morgan | Outperform | $12 |
| 2009-11-17 | Initiated | Deutsche Securities | Buy |
| 2016-06-29 | Reiterated Rating | FBR & Co. | Outperform | |
| 2016-06-29 | Reiterated Rating | FBR & Co | Outperform | $38.00 |
| 2016-06-14 | Reiterated Rating | WBB Securities | Buy | $75.00 |
| 2016-06-04 | Initiated Coverage | Maxim Group | Buy | |
| 2016-06-02 | Initiated Coverage | Cantor Fitzgerald | Buy | $21.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In OMER 83 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| INGALLS & SNYDER LLC | 4.09M |
| Vanguard Group, Inc | 2.82M |
| D. E. Shaw & Co., Inc. | 2.01M |
| BlackRock Fund Advisors | 1.93M |
| STIFEL FINANCIAL CORP | 1.38M |
| BlackRock Inc. | 1.14M |
| BlackRock Institutional Trust Company, N.A. | 1.10M |
| UBS Group AG | 0.65M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.60M |
| ROYAL BANK OF CANADA | 0.59M |
| NOMURA HOLDINGS INC | 0.56M |
| BANK OF MONTREAL /CAN/ | 0.56M |
| CITADEL ADVISORS LLC | 0.41M |
| WELLINGTON MANAGEMENT CO LLP | 0.38M |
| MORGAN STANLEY | 0.37M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Demopulos Gregory A MD Chairman, CEO & President | 5.84% (1987025) | OMER / |
| Tripet Jean-Philippe | 1.45% (493102) | OMER / |
| Kelbon Marcia S. VP Patent and General Counsel | 0.70% (239169) | OMER / |
| Demopulos Peter A MD | 0.54% (185182) | OMER / |
| Hood Leroy E. MD PhD | 0.16% (54390) | OMER / |
| Aspiri Ray | 0.12% (40306) | OMER / |
| Cable Thomas J. | 0.12% (40067) | OMER / |
| JACOBSEN MICHAEL A VP Finance and CAO | 0.03% (8500) | OMER / SRPT / |
| HANISH ARNOLD C | 0.01% (2400) | OMER / |
UM